SUMMARY -Mesonephric adenocarcinoma is a rare variant of cervical adenocarcinoma. We present a case of mesonephric adenocarcinoma of endocervix with cervical and vaginal lobular mesonephric hyperplasia in a 57-year-old woman. Vaginal bleeding persisting for 12 months was the only symptom. Histopathologic fi ndings and characteristic immunophenotype are crucial for the diagnosis. Th e tumor was composed of papillary formation with a central fi brovascular stroma, villoglandular and densely compact tubular structures containing intraluminal eosinophilic secretion, and coated with one or more rows of cylindrical atypical epithelial cells. Th ere were 30 pathologic mitotic shapes found per 10 HPF. Th e tumor invaded nearly full-thickness of cervical stroma with positive lymphovascular space invasion and clear margins. Th e case demonstrated characteristic cytokeratin 7, vimentin and epithelial membrane antigen positivity and high Ki-67 proliferation index (60%). Estrogen receptors, progesterone receptors and carcinoembryonic antigen were negative. Intratubular lumen secretion was periodic acid-Schiff positive with periodic acid-Schiff negative carcinoma cells. Diff erential diagnoses include adenoma malignum, well-diff erentiated villoglandular adenocarcinoma, endometrioid adenocarcinoma, serous adenocarcinoma, mesonephric adenocarcinoma with a sarcomatous component, clear-cell carcinoma and mesonephric hyperplasia. Radical hysterectomy with bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy was performed. Th ree years after the surgery, the patient remains well. Th ere has not been any evidence of local or distant recurrence. Th ere are no specifi c recommendations for the treatment of this rare disease. It remains uncertain whether surgical approach is suffi cient or the treatment should include additional radio/chemotherapy.
Introduction
Malignant mesonephric tumors are derived from remnants of the mesonephric (wollfi an) ducts. In the absence of testosterone, the mesonephric ducts regress. Remnants may persist as the epoophoron, Skene's glands and Gartner's duct. Th ey are usually located in the uterine cervix, lateral wall of the vagina, broad ligament, mesosalpinx and in the ovarian hilium 1 . Mesonephric duct remnants are found in 10%-22% of adult uterine cervices 2, 3 . Hyperplasia of these remnants is a benign lesion that is almost always discovered incidentally in cone biopsy or hysterectomy specimens 1, 4 . Ma-lignant mesonephric tumor, arising from mesonephric duct hyperplasia or mesonephric remnants, is an extremely rare variant of cervical adenocarcinoma 5 , with 35 cases reported in the literature 4, 6, 7 . We present a case of mesonephric adenocarcinoma of uterine cervix associated with lobular mesonephric hyperplasia. Clinical, pathological and immunohistochemical characteristics are discussed.
Case Report
A 57-year-old postmenopausal woman presented for vaginal bleeding persisting for 12 months. Endocervical curettage and cervical adenocarcinoma diagnosis were made at an external institution. Her previous medical history was not signifi cant and included only hypertension. Physical examination revealed appropriate external genitals, medium large vagina with some active bleeding from the uterine cervix. Th ere were no signs of infection, infl ammation or other abnormalities of uterine cervix. Uterus was of normal size, movable and painless. Bilateral parametria were free. Transvaginal ultrasonography showed a 5.6x4.5 cm solid mass in the uterine corpus and 1.9x2.7 cm hyperechoic formation in the uterine cervix. Magnetic resonance imaging (MRI) showed a uterine cervical mass measuring 4 cm in diameter. Th ere was no signifi cant lymphadenopathy. Th e patient underwent radical hysterectomy with bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy. Postoperative period passed without any complications. Histopathologic and immunohistochemical analysis confi rmed the diagnosis of mesonephric adenocarcinoma of uterine cervix, lobular mesonephric hyperplasia, adenomyosis and leiomyoma of the uterus. Th e macroscopic intersection of the hysterectomy specimen showed a soft tumor mass measuring 5.5x4 cm in the cervix and lower uterine segment. Th e tumor was composed of papillary formation with central fibrovascular stroma (Fig. 1) , villoglandular and densely compact tubular structures containing intraluminal eosinophilic secretion, and coated with one or more rows of cylindrical atypical epithelial cells with vesicular nuclei which were interspersed and had the appearance of ground glass. Th ere were 30 pathologic mitotic shapes found per 10 high power fi elds (HPF). Th e tumor invaded nearly full-thickness of cervical stroma with positive lymphovascular space invasion and clear margins. In the adjacent area of adenocarcinoma, lobular mesonephric hyperplasia was observed (Fig. 2) . Th e hyperplastic mesonephric tubules were also found in fornices of the vagina, also containing intraluminal eosinophilic secretion. Compared to adenocarcinoma, there was no cytologic atypia.
Immunohistochemically, neoplastic cells were diffusely positive for cytokeratin 7, vimentin, epithelial membrane antigen (EMA), and focally positive for p53. Th e adenocarcinoma component was negative for estrogen receptors (ER), progesterone receptors (PR), and carcinoembryonic antigen (CEA). Proliferation index Ki-67 was 60%. Th e intratubular lumen secretion was periodic acid-Schiff (PAS) positive, while that stain was absent in the adenocarcinoma cells. Based on these morphological and immunohistochemical features, the diagnosis of mesonephric adenocarcinoma, International Federation of Gynecology and Obstetrics (FIGO) IB2, with lobular mesonephric hyperplasia was confi rmed. Para-aortic (n=12) and pelvic (n=32) lymph nodes were negative for metastasis. Th e patient has had regular checkups. To date, three years after the surgery, the patient remains well. Th ere has not been any evidence of local or distant recurrence.
Discussion
Proliferative mesonephric lesions are extremely rare. Our patient was aged 57, and according to Anagnostopoulos et al. 7 , the mean age of patients with mesonephric adenocarcinomas of uterine cervix was 50.7 years, age range between 24 and 73 years. Usually, most cases were diagnosed at an early stage of the disease, FIGO IB, presenting with abnormal vaginal bleeding, pelvic pain, dyspareunia, uterine prolapse or abnormal Pap smear [6] [7] [8] . In this particular case, the disease was diagnosed at an early stage, more precisely FIGO IB2. Abnormal vaginal bleeding was the only symptom. Th e etiology of mesonephric adenocarcinoma is not related to the human papillomavirus 8 . Th e combination of histopathologic and immunohistochemical analysis of tumor tissue is crucial in differential diagnosis of most cervical glandular lesions. Mesonephric adenocarcinomas of uterine cervix, which are presumed to arise from mesonephric hyperplasia or mesonephric remnants, are characterized by morphological diversity and an unusual appearance 6 . Diff erential diagnoses include adenoma malignum, well-diff erentiated villoglandular adenocarcinoma, endometrioid adenocarcinoma, serous adenocarcinoma, mesonephric adenocarcinoma with a sarcomatous component, clear-cell carcinoma and mesonephric hyperplasia 6, 7, 9 . In almost all cases reported in the literature, mesonephric hyperplasia classifi ed as diff use mesonephric hyperplasia, ductal mesonephric hyperplasia and lobular mesonephric hyperplasia was observed adjacent to mesonephric adenocarcinoma, especially lobular and diff use subtypes 6 . Th ese categories of mesonephric hyperplasia have no clinical signifi cance but they may be misinterpreted as premalignant or malignant lesions and pathologists should be aware of this possibility 4, 10 . In our case, lobular mesonephric hyperplasia was found next to the area of adenocarcinoma and also in fornices of the vagina, but compared to adenocarcinoma, there was no cytologic atypia. Th e diff use form of mesonephric hyperplasia may extend deeply into the cervical wall mimicking minimal deviation adenocarcinoma 11 . Appropriate patient management requires correct classifi cation of mesonephric lesions. Th e histopathologic characteristics of mesonephric adenocarcinoma that help diff erentiate these lesions from adenoma malignum are cytologic atypia and lack of intracytoplasmic mucin 6 . Th e presence of sarcomatous components is the key to carcinosarcoma diagnosis 8 . Only 16% of carcinosarcomas reported in the English literature were of mesonephric duct origin 2 . Th e typical histologic features of clear-cell cytoplasm and hobnail cell pattern, and the presence of PAS positive intraluminal secretion with PAS positive intracytoplasmic globules direct us to the diagnosis of clear-cell carcinoma 9 . Th e absence of mesonephric hyperplasia is associated with endometrioid adenocarcinoma and clear-cell carcinoma 6 . Our case demonstrated characteristic cytokeratin 7, vimentin and EMA positivity, high Ki-67 proliferation index (60%), negative ER, PR, CEA and PAS positive intraluminal secretion with PAS negative carcinoma cells. Recent reports showed that immunohistochemical features of mesonephric adenocarcinoma included positivity for epithelial markers including pancytokeratin, CK7, CAM5.2 and EMA 7, 9 . Vimentin is positive in 70% and calretinin in 88% of cervical mesonephric adenocarcinoma, while CK20, ER, PR and CEA are usually negative 7, 9 . Th is staining profi le is crucial in the diff erential diagnosis, especially with endometrioid and other paramesonephric adenocarcinomas, with which it may be confused. Th e expression of p53 and/or CD10 is also useful in establishing the diagnosis of mesonephric neoplasm. CD10 has been suggested as a marker for all mesonephric lesions in the female genital tract, although there are cases of CD10 negative mesonephric adenocarcinomas reported in the literature 4, 6, 9 . Most other benign endocervical glandular lesions are negative for CD10 4 . A high Ki-67 (>40%) proliferative index is a feature of malignant lesions 12 .
Th ere are no defi nite recommendations for the treatment and follow up of this uncommon disease. According to the current guidelines for cervical adenocarcinoma, surgery should be the primary choice for localized disease 13, 14 . Surgical treatment implies radical hysterectomy, pelvic lymphadenectomy and, for patients with larger tumors and/or positive pelvic lymph nodes, para-aortic lymphadenectomy 13, 14 . According to Bagué et al. 15 , surgery alone should be the treatment of choice. In our case, surgery was the only treatment and three years thereafter, there has been no evidence of local or distant recurrence. Th e role of chemotherapy and radiotherapy is unclear; there is little evidence for their effi cacy 3 . Postoperative radiotherapy decreases the risk of disease progression to stage IB cervical cancer, with doubtful impact on overall survival 16 . A review of the literature showed that chemotherapy might be considered as palliative treatment in patients with recurrence 3, 17, 18 . According to Anagnostopoulos et al. 7 , the mean disease-free interval for stage IB disease is 48.6 months, with recurrence rate of 23% after surgery as primary treatment.
Conclusion
Th is case report draws attention to the importance of considering mesonephric adenocarcinoma in the diff erential diagnosis of cervical carcinoma. Although this type of tumor is rare, it is necessary to defi ne specifi c recommendations for treatment, which would lead to better follow up and overall survival. Our case contributes to the scarce knowledge of this rare disease and can help in proposing the treatment and follow up guidelines.
